Effect of combination of ezetimibe and a statin on coronary plaque regression in patients with acute coronary syndrome: ZEUS trial (eZEtimibe Ultrasound Study)

IJC Metabolic and Endocrine

Volumn 3, Issue , 2014, Pages 8-13

  Nakajima, Naohisa ^a   Miyauchi, Katsumi ^a   Yokoyama, Takayuki ^a   Ogita, Manabu ^a   Miyazaki, Tadashi ^a   Tamura, Hiroshi ^b   Nishino, Akihisa ^a   Yokoyama, Ken ^a   Okazaki, Sinya ^a   Kurata, Takeshi ^a   Suwa, Satoru ^b   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

ACS; Coronary plaque; Diabetes; IVUS; LDL C

Indexed keywords

ATORVASTATIN; EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLYCERYL TRINITRATE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY PLAQUE REGRESSION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PLAQUE VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; ABSENCE OF SIDE EFFECTS; ATHEROMA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY OCCLUSION;

EID: 84901493493     PISSN: 22147624     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcme.2014.03.001     Document Type: Article

References (22)

1. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
2. Baigent C., Blackwell L., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010, 376:1670-1681. Cholesterol Treatment Trialists' (CTT) Collaboration.
3. Mihaylova B., Emberson J., et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012, 380:581-590. Cholesterol Treatment Trialists' (CTT) Collaborators.
4. Sipahi I., Nicholls S.J., Tuzcu E.M., Nissen S.E. Coronary atherosclerosis can regress with very intensive statin therapy. Cleve Clin J Med 2006, 73:937-944.
5. Puri R., Nissen S.E., Ballantyne C.M., et al. Factors underlying regression of coronary atheroma with potent statin therapy. Eur Heart J 2013, 34:1818-1825.
6. Miyauchi K., Daida H. Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease: LDL-cholesterol: the lower, the better; is it true for Asians? (Pro). Circ J 2010, 74:1718-1730.
7. Hattori K., Ozaki Y., Ismail T.F., et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging 2012, 5:169-177.
8. Nissen S.E., Nicholls S.J., Sipahi I., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006, 295:1556-1565.
9. Okazaki S., Yokoyama T., Miyauchi K., et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004, 110:1061-1068.
10. Hiro T., Kimura T., Morimoto T., et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS study). J Am Coll Cardiol 2009, 54:293-302.
11. Dohi T., Miyauchi K., Okazaki S., et al. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study. Atherosclerosis 2010, 210:497-502.
12. Nicholls S.J., Ballantyne C.M., Barter P.J., et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 2011, 365:2078-2087.
13. Kastelein J.J., Akdim F., Stroes E.S., et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, 358:1431-1443.
14. Arai H., Hiro T., Kimura T., et al. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome. J Atheroscler Thromb 2010, 17:1096-1107.
15. Robinson J.G., Stone N.J. Identifying patients for aggressive cholesterol lowering: the risk curve concept. Am J Cardiol 2006, 98:1405-1408.
16. Inaba S., Okayama H., Funada J.I., et al. Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. Eur Heart J Cardiovasc Imaging Feb 24 2012.
17. Nasu K., Tsuchikane E., Katoh O., et al. Plaque characterisation by virtual histology intravascular ultrasound analysis in patients with type 2 diabetes. Heart 2008, 94:429-433.
18. Kaplan M., Kerry R., Aviram M., Hayek T. High glucose concentration increases macrophage cholesterol biosynthesis in diabetes through activation of the sterol regulatory element binding protein 1 (SREBP1): inhibitory effect of insulin. J Cardiovasc Pharmacol 2008, 52:324-332.
19. Williams K.J., Feig J.E., Fisher E.A. Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med 2008, 5:91-102.
20. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998, 97:2433-2444.
21. Kawasaki M., Sano K., Okubo M., et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005, 45:1946-1953.
22. Nakamura H., Arakawa K., Itakura H., et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006, 368:1155-1163.